Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company trades in pharmaceutical products. Prepares financial statements under SME financial reporting standards.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 7,531 | 10,394 | 10,852 | 14,740 | 5,209 | 5,478 | -6.2% |
| Total COGS | 3,257 | 4,146 | 5,128 | 6,288 | 3,641 | 1,743 | nmf |
| Gross Profit | 10,788 | 6,247 | 5,724 | 8,452 | 1,568 | 3,735 | -19.1% |
| Gross Margin | 143.2% | 60.1% | 52.7% | 57.3% | 30.1% | 68.2% | |
| 90 | 138 | 278 | 220 | 196 | 4 | -45.3% | |
| EBITDA | 10,878 | 6,385 | 5,446 | 8,232 | 1,764 | 3,739 | -19.2% |
| EBITDA Margin | 144.4% | 61.4% | 50.2% | 55.8% | 33.9% | 68.3% | |
| Total D&A | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT / Operating Income | 10,878 | 6,385 | 5,446 | 8,232 | 1,764 | 3,739 | -19.2% |
| Total Other Income | 151 | 0 | 28 | 0 | 121 | 17 | -35.7% |
| Profit Before Tax | 11,029 | 6,385 | 5,474 | 8,232 | 1,885 | 3,755 | -19.4% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 7,621 | 6,385 | 5,446 | 8,232 | 1,623 | 3,739 | -13.3% |
| Net Margin | 101.2% | 61.4% | 50.2% | 55.8% | 31.2% | 68.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →